Ignite Creation Date:
2024-05-05 @ 11:44 PM
Last Modification Date:
2024-10-26 @ 10:39 AM
Study NCT ID:
NCT01408641
Status:
TERMINATED
Last Update Posted:
2022-03-03
First Post:
2011-08-01
Brief Title:
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
A 14-week Randomized Placebo-controlled Study of Topiramate for Alcohol Use Disorders in Veterans With Posttraumatic Stress Disorder
Status:
TERMINATED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Principal Investigator was deployed overseas
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Alcohol abuse and dependence alcohol use disorders AUDs and posttraumatic stress disorder PTSD are both prevalent in Veterans Treating AUDs in Veterans with PTSD may be more difficult than treating AUDs in the general population The FDA-approved medication topiramate has been shown to improve drinking outcomes in people with AUDs Topiramate has also improved symptoms in people with PTSD This study is designed to investigate whether topiramate will improve drinking outcomes in Veterans with PTSD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None